HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Comparative effects of the 5'-triphosphates of 9-beta-(2'-azido-2'-deoxy-D-arabinofuranosyl)adenine and 9-beta-D-arabinofuranosyladenine on DNA polymerases from L1210 leukemia cells.

Abstract
9-beta-(2'-Azido-2'-deoxy-D-arabiofuranosyl)adenine (arazide) causes greater and significantly more persistent inhibition of [3H]-thymidine incorporation into the DNA of neoplastic cells than the related agent 9-beta-D-arabinofuranosyladenine (araA). To elucidate the mechanism(s) responsible, we compared the effects of arazide and araA 5'-triphosphates on DNA polymerases alpha and beta of L1210 leukemia cells. Both nucleoside triphosphate analogs inhibited DNA polymerase alpha activity by competing with dATP; only araATP was inhibitory to DNA polymerase beta. Arazide triphosphate was at least four times more active than araATP as an inhibitor of DNA polymerase alpha. Preincubation of DNA polymerase alpha with either agent did not result in enzyme inactivation. The results suggest that interference with DNA polymerase alpha activity by arazide triphosphate may be in part responsible for the inhibition of DNA synthesis produced by arazide in neoplastic cells.
AuthorsH S Allaudeen, J W Kozarich, A C Sartorelli
JournalNucleic acids research (Nucleic Acids Res) Vol. 10 Issue 4 Pg. 1379-87 (Feb 25 1982) ISSN: 0305-1048 [Print] England
PMID6175955 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Arabinonucleotides
  • Vidarabine Phosphate
  • ara-ATP
  • arazide
  • arazide 5'-triphosphate
  • DNA Polymerase I
  • DNA Polymerase II
  • DNA-Directed DNA Polymerase
  • Vidarabine
Topics
  • Animals
  • Arabinonucleotides (pharmacology)
  • DNA Polymerase I (metabolism)
  • DNA Polymerase II (metabolism)
  • DNA-Directed DNA Polymerase (metabolism)
  • Kinetics
  • Leukemia L1210 (enzymology)
  • Mice
  • Vidarabine (analogs & derivatives, pharmacology)
  • Vidarabine Phosphate (analogs & derivatives, pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: